AKT1 and glioma: (-)-Aplysin (304) is also effective against human glioma cells by increasing miR-181 expression, sensitizing the cytotoxic effects of the alkylating drug temozolomide, and inducing cell cycle arrest and apoptosis through the inhibition of the PI3K/Akt signaling, which is relevant in the survival of glioma cells [683].